Gallocin A, an Atypical Two-Peptide Bacteriocin with Intramolecular Disulfide Bonds Required for Activity
Alexis Proutière, Laurence du Merle, Marta Garcia-Lopez, Corentin Léger, Alexis Voegele, Alexandre Chenal, Antony Harrington, Yftah Tal‐Gan, Thomas Cokelaer, Patrick Trieu‐Cuot, Shaynoor Dramsi
Abstract
Streptococcus gallolyticus subsp. gallolyticus ( SGG ), previously named Streptococcus bovis biotype I, is an opportunistic pathogen responsible for invasive infections (septicemia, endocarditis) in elderly people and is often associated with colon tumors. SGG is one of the first bacteria to be associated with the occurrence of colorectal cancer in humans. Previously, we showed that tumor-associated conditions in the colon provide SGG with an ideal environment to proliferate at the expense of phylogenetically and metabolically closely related commensal bacteria such as enterococci (1). SGG takes advantage of CRC-associated conditions to outcompete and substitute commensal members of the gut microbiota using a specific bacteriocin named gallocin, recently renamed gallocin A following the discovery of gallocin D in a peculiar SGG isolate.